Two Rare Causes of Anterior Pseudo-Uveitis Affecting the Iris: Sequelae of Bilateral Acute Iris Transillumination (BAIT) Syndrome and Iridocorneal Endothelial (ICE) Syndrome

Ioannis Papasavvas; Phuc LeHoang; Carl Peter Herbort jr.

doi:10.1055/a-1354-6305

Klinische Monatsblätter für Augenheilkunde, Table of Contents

Klin Monbl Augenheilkd 2021; 238(04): 443-447
DOI: 10.1055/a-1354-6305

Der interessante Fall

Two Rare Causes of Anterior Pseudo-Uveitis Affecting the Iris: Sequelae of Bilateral Acute Iris Transillumination (BAIT) Syndrome and Iridocorneal Endothelial (ICE) Syndrome

Zwei seltene Ursachen für eine vordere Pseudouveitis mit Beeinträchtigung der Iris: Folgeschäden eines bilateralen akuten Iristransilluminationssyndroms (BAIT) und das iridokorneale endotheliale (ICE) Syndrom

Ioannis Papasavvas

¹Retinal and Inflammatory Eye Diseases, Centre for Ophthalmic Specialized Care (COS), Clinic Montchoisi Teaching Centre, Lausanne

,

Phuc LeHoang

²Department of Ophthalmology, La Pitié-Salpétrière Hospital, Sorbonne University, Paris, France & Hôpital dʼInstruction des Armées Percy, Clamart, France

,

Carl Peter Herbort jr.

¹Retinal and Inflammatory Eye Diseases, Centre for Ophthalmic Specialized Care (COS), Clinic Montchoisi Teaching Centre, Lausanne

› Author Affiliations

Abstract

Full Text

References

References
1 Bringas Calvo R, Iglesias Cortiñas D. [Acute and bilateral uveitis secondary to moxifloxacin]. Arch Soc Esp Oftalmol 2004; 79: 357-359
2 Tranos P, Lokovitis E, Masselos S. et al. Bilateral acute iris transillumination following systemic administration of antibiotics. Eye (Lond) 2018; 32: 1190-1196 doi:10.1038/s41433-018-0054-y
3 Tugal-Tutkun I, Onal S, Garip A. et al. Bilateral acute iris transillumination. Arch Ophthalmol 2011; 129: 1312-1319
4 Wefers Bettink-Remeijer M, Brouwers K, van Lagenhove L. et al. Uveitis-like syndrome and iris transillumination after the use of oral moxifloxacin. Eye (Lond) 2009; 23: 2260-2262
5 Perone JM, Chaussard D, Hayek G. Bilateral acute iris transillumination (BAIT) syndrome: literature review. Clin Ophthalmol 2019; 13: 395-943
6 Sachetti M, Mantelli F, Marenco M. et al. Diagnosis and management of iridocorneal endothelial syndrome. Biomed Res Int 2015; 2015: 763093 doi:10.1155/2015/763093
7 Yanoff M. Iridocorneal endothelial syndrome: unification of a disease spectrum. Surv Ophthalmol 1979; 24: 1-2
8 Shields MB. Progressive essential iris atrophy, Chandlerʼs syndrome, and iris nevus (Cogan-Reese) syndrome: a spectrum of disease. Surv Ophthalmol 1979; 24: 3-20
9 Boberg-Ans J. Essential progressive iris atrophy. Br J Ophthalmol 1969; 53: 649-651
10 Harms C. Einseitige spontane Lückenbildung der Iris durch Atrophie ohne mechanische Zerrung. Klin Monbl Augenheilk 1903; 41: 522-528
11 Patel A, Kenyon KR, Hirst LW. et al. Clinicopathologic features of Chandlerʼs syndrome. Surv Ophthalmol 1983; 27: 327-344
12 Chandler PA. Atrophy of the stroma of the iris: endothelial dystrophy, corneal edema, and glaucoma. Am J Ophthalmol 1956; 41: 607-615
13 Scheie HG, Yanoff M. Iris nevus (Cogan-Reese) syndrome. A cause of unilateral glaucoma. Arch Ophthalmol 1975; 93: 563-570
14 Cogan DG, Reese AB. A syndrome of iris nodules, ectopic Descemetʼs membrane and unilateral glaucoma. Doc Ophthalmol 1969; 26: 424-433
15 Alvarado JA, Underwood JL, Green WR. et al. Detection of Herpes Simplex DDNA in the iridocorneal endothelial syndrome. Arch Ophthalmol 1994; 112: 1601-1609
16 Hooks JJ, Kupfer C. Herpes Simplex in iridocorneal endothelial syndrome. Arch Ophthalmol 1995; 113: 1226-1228
17 Tugal-Tutkun I, Urgancioglu M. Bilateral acute depigmentation of the iris. Graefes Arch Clin Exp Ophthalmol 2006; 244: 742-746
18 Bayraktar S, Oray M, Altan C. et al. Long-term results of trabeculectomy with Mitomycin-C in patients with bilateral acute iris transillumination. J Glaucoma 2019; 28: 797-802
19 Ong-Tone L. Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given by different methods before cataract surgery. J Cataract Refract Surg 2007; 33: 59-62
20 Gomes RLR, Viana RG, Melo LAS. Aqueous humor penetration and biological activity of moxifloxacin 0.5 % ophthalmic solution alone or with dexamethasone 0.1. J Ocul Pharmacol Ther 2017; 33: 98-102
21 Hariprasad SM, Blinder KJ, Shah GK. et al. Penetration pharmacokinetics of topically administered 0.5 % moxifloxacin ophthalmic solution in human aqueous and vitreous. Arch Ophthalmol 2005; 123: 39-44
22 Hariprasad SM, Shah GK, Mieler WF. et al. Vitreous and aqueous penetration of orally administered moxifloxacin in humans. Arch Ophthalmol 2006; 124: 178-182
23 Vendantham V, Lalitha P, Velpandian T. et al. Vitreous and aqueous penetration of orally administered moxifloxacin in humans. Eye (Lond) 2006; 20: 1273-1278
24 Chaurasia S, Ramappa M, Garg P. et al. Endothelial keratoplasty in the management of irido-corneal endothelial syndrome. Eye (Lond) 2013; 27: 564-566
25 Tugal-Tutkun I, Araz B, Taskapili M. et al. Bilateral acute depigmentation of the iris: report of 26 new cases and four-year follow-up of two patients. Ophthalmology 2009; 116: 1552-1557
26 Scuderi G, Contestabile MT, Scuderi L. et al. Pigment dispersion syndrome and pigmentary glaucoma: a review and update. Int Ophthalmol 2019; 39: 1651-1662
27 Chrystal PW, Walter MA. Aniridia and Axenfeld-Rieger syndrome: clinical presentations, molecular genetics and current/emerging therapies. Exp Eye Res 2019; 189: 107815 doi:10.1016/j.exer.2019.107815
28 Laganowski HC, Sherrard ES, Muir MG. et al. Distinguishing features of the iridocorneal endothelial syndrome and posterior polymorphous dystrophy: value of endothelial specular microscopy. Br J Ophthalmol 1991; 75: 212-216 doi:10.1136/bjo.75.4.212